Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride reduces testosterone conversion, progesterone lessens this, and levamisole enhances finasteride's effect.

The Spanish HSS-29 scale effectively measures changes in life quality due to female-pattern hair loss.

5-alpha reductase inhibitors and spironolactone don't increase gynecological tumor risk, glucagon-like-peptide-1 receptor agonists may increase alopecia risk, sanitary pads can cause dermatitis, early hidradenitis suppurativa intervention is crucial for Hispanic patients, community education boosts skin cancer awareness, metformin may improve skin cancer survival, LNG-IUDs can increase acne risk, machine learning accurately detects basal cell carcinoma, JAK-inhibitors may raise miscarriage risk, inclusive skincare ads affect those with darker skin, and CCCA in Black women might involve autoimmunity.

5α-reductase inhibitors are effective for treating hair loss in androgenetic alopecia.

Inhibitors of the enzyme 5 alpha-reductase could potentially treat disorders like prostate cancer and baldness.

New pyrazole derivatives may help treat hair loss, but more testing is needed.

Plant-based treatments may help reduce BPH symptoms, but more research is needed.

BPH treatment improved with personalized medicine, new drugs, and less invasive surgeries.

The document concludes that the risk of sexual side effects from 5-alpha-reductase inhibitors is low and often temporary, but more research is needed on potential permanent effects.

Dapsone gel 5% is effective and safe for treating acne.

α-Blockers and 5-ARIs for BPH can cause sexual dysfunction, including erectile and ejaculatory issues.

Combination therapy is more effective for prostate volumes over 60 ml.

People with androgenetic alopecia had milder COVID-19 symptoms during the Omicron wave in China.

Finasteride's negative effects on brain tissue in male rats may be reversible after stopping the drug.

Caffeine can stimulate hair growth, but the best dose and frequency for hair loss treatment are still unknown.

PrEP doesn't increase STI risk in high-risk men, anti-androgen drugs may lower ICU admission for male COVID-19 patients, a 3-point injection is better for crow's feet, and the 'Geriatric-8' tool could help assess frailty in older skin cancer patients.

Finasteride and dutasteride are effective for male hair loss and enlarged prostate but may cause reversible sexual side effects.

Dutasteride improved hair density and thickness in men not helped by finasteride, with minimal side effects.

Finasteride helps improve treatment for benign prostatic hyperplasia.

5-alpha-reductase inhibitors can effectively treat benign prostatic hyperplasia.

Blocking 5α-reductase can reduce sleep deprivation-related behavioral issues in rats.

Finasteride treatment makes the prostate look more like a healthy one.

Dutasteride is more effective than finasteride for treating BPH without extra safety risks.

Topical finasteride with EGCG or TA improves drug release and dermal uptake, potentially treating hair loss effectively.

Finasteride treatment changes hormone levels in male pattern baldness patients.

Taking 5-ARI before prostate laser surgery may lead to more blood changes, longer surgery, and more urinary issues.

There's not enough data on finasteride's sexual side effects.

Vitamin E affects liver metabolism, enhancing stress resistance, reducing blood clotting, and altering hormone processing.

Androgen increases VEGF expression but not VEGFR-2 in rat corpus cavernous.

Combining dutasteride or finasteride with an α1 blocker is more effective for managing BPH than using either alone.